Incidence and Risk Factors for Low Anterior Resection Syndrome following Trans-Anal Total Mesorectal Excision

医学 全直肠系膜切除术 吻合 结直肠癌 入射(几何) 外科 风险因素 辅助治疗 癌症 内科学 光学 物理 化疗
作者
S. Y. Parnasa,Ido Mizrahi,Brigitte Helou,Adiel Cohen,Mahmoud Abu Gazala,Alon J. Pikarsky,Noam Shussman
出处
期刊:Journal of Clinical Medicine [Multidisciplinary Digital Publishing Institute]
卷期号:13 (2): 437-437 被引量:1
标识
DOI:10.3390/jcm13020437
摘要

Background: Trans-anal total mesorectal excision (Ta-TME) is a novel approach for the resection of rectal cancer. Low anterior resection syndrome (LARS) is a frequent functional disorder that might follow restorative proctectomy. Data regarding bowel function after Ta-TME are scarce. The aim of this study was to evaluate the incidence and risk factors for the development of LARS following Ta-TME. Methods: A prospectively maintained database of all patients who underwent Ta-TME for rectal cancer at our institution was reviewed. All patients who were operated on from January 2018 to December 2021 were evaluated. The LARS score questionnaire was used via telephone interviews. Incidence, severity and risk factors for LARS were evaluated. Results: Eighty-five patients underwent Ta-TME for rectal cancer between January 2018 and December 2021. Thirty-five patients were excluded due to ostomy status, death, local disease recurrence, ileal pouch or lack of compliance. Fifty patients were included in the analysis. LARS was diagnosed in 76% of patients. Anastomosis distance from dentate line was identified as a risk factor for LARS via multivariate analysis (p = 0.042). Neo-adjuvant therapy, hand sewn anastomosis and anastomotic leak did not increase the risk of LARS. Conclusion: LARS is a frequent condition following ta-TME, as it is used for other approaches to low anterior resection. Anastomosis distance from dentate line is an independent risk factor for LARS. In this study neo-adjuvant therapy, hand sewn anastomosis and anastomotic leak did not increase the risk of LARS. Further studies with longer follow-up times are required to better understand the functional outcomes following Ta-TME.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
荔枝完成签到,获得积分10
刚刚
今天的风儿甚是喧嚣完成签到,获得积分10
1秒前
snowy_owl完成签到,获得积分10
2秒前
科研通AI5应助神奇的种子采纳,获得10
3秒前
呱呱完成签到 ,获得积分10
3秒前
hlh发布了新的文献求助50
3秒前
3秒前
星星之火完成签到,获得积分10
3秒前
3秒前
希音完成签到,获得积分10
3秒前
3秒前
3秒前
小董不懂完成签到,获得积分10
3秒前
an完成签到,获得积分20
4秒前
隐形静芙完成签到 ,获得积分10
4秒前
llc完成签到,获得积分10
5秒前
5秒前
5秒前
zhang完成签到,获得积分10
5秒前
77发布了新的文献求助10
5秒前
6秒前
深情安青应助sdnihbhew采纳,获得10
6秒前
6秒前
认真白薇发布了新的文献求助10
8秒前
bc应助是是是采纳,获得10
8秒前
无花果应助hangboy采纳,获得10
8秒前
8秒前
afree发布了新的文献求助10
8秒前
Asiprinal发布了新的文献求助10
8秒前
8秒前
zhang发布了新的文献求助10
9秒前
落月铭发布了新的文献求助10
9秒前
xzf1996发布了新的文献求助10
9秒前
10秒前
zQiao完成签到,获得积分10
10秒前
大反应釜发布了新的文献求助10
11秒前
11秒前
RDF完成签到,获得积分10
11秒前
拉普兰Z完成签到,获得积分10
11秒前
11秒前
高分求助中
【此为提示信息,请勿应助】请按要求发布求助,避免被关 20000
CRC Handbook of Chemistry and Physics 104th edition 1000
Izeltabart tapatansine - AdisInsight 600
ISCN 2024 – An International System for Human Cytogenomic Nomenclature (2024) 500
An International System for Human Cytogenomic Nomenclature (2024) 500
Introduction to Comparative Public Administration Administrative Systems and Reforms in Europe, Third Edition 3rd edition 500
Distinct Aggregation Behaviors and Rheological Responses of Two Terminally Functionalized Polyisoprenes with Different Quadruple Hydrogen Bonding Motifs 450
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3767694
求助须知:如何正确求助?哪些是违规求助? 3312340
关于积分的说明 10163291
捐赠科研通 3027644
什么是DOI,文献DOI怎么找? 1661614
邀请新用户注册赠送积分活动 794172
科研通“疑难数据库(出版商)”最低求助积分说明 756013